<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948425</url>
  </required_header>
  <id_info>
    <org_study_id>AVC AIGUS</org_study_id>
    <secondary_id>2017/12AVR/209</secondary_id>
    <nct_id>NCT03948425</nct_id>
  </id_info>
  <brief_title>Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke</brief_title>
  <acronym>AVC_AIGUS</acronym>
  <official_title>Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Generate a dynamic mapping of the distribution of iodine within the cerebral parenchyma&#xD;
           in the patient suspected of acute ischemic disorder with the CT spectral scanner.&#xD;
&#xD;
        -  Correlate the anomalies of iodine mapping to the other parameters acquired during the&#xD;
           classic dynamic infusion phase to define the ischemic area (MTT higher and rCBV normal)&#xD;
           versus infarcted zone (MTT higher and rCBV decreased)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral Blood Volume (CBV)</measure>
    <time_frame>from start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>CBV is measured in units of milliliters of blood per 100 g of brain and is defined as the volume of flowing blood for a given volume of brain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Transit Time (MTT)</measure>
    <time_frame>rom start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>MTT is measured in seconds and defined as the average amount of time it takes blood to transit through the given volume of brain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral Blood Flow (CBF)</measure>
    <time_frame>rom start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>CBF is measured in units of milliliters of blood per 100 g of brain tissue per minute and is defined as the volume of flowing blood moving through a given volume of brain in a specific amount of time.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical suspicion of hyperacute stroke (6 hours after onset of symptoms):Intervention 'spectral CT'</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>spectral CT</intervention_name>
    <description>Head spectral CT</description>
    <arm_group_label>Stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical suspicion of hyperacute stroke (6 hours after onset of symptoms)&#xD;
&#xD;
          -  Age between 50 and 95 years&#xD;
&#xD;
          -  Weight: between 65 and 95 kg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented or suspected allergy to IV iodinated contrast media&#xD;
&#xD;
          -  Renal impairment with creatinine clearance &lt;60 ml / min&#xD;
&#xD;
          -  Hemorrhagic lesions or vascular abnormalities demonstrated on CT before contrast&#xD;
             injection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Coche, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques universitaires saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

